Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
14.17
+0.64 (4.73%)
At close: May 26, 2026, 4:00 PM EDT
14.55
+0.38 (2.68%)
After-hours: May 26, 2026, 7:39 PM EDT
Relay Therapeutics Employees
Relay Therapeutics had 193 employees as of March 31, 2026. The number of employees decreased by 66 or -25.48% compared to the same quarter last year.
Employees
193
Change
-66
Growth
-25.48%
Revenue / Employee
$55,316
Profits / Employee
-$1,412,979
Market Cap
3.09B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 193 | -66 | -25.48% |
| Dec 31, 2025 | 192 | -69 | -26.44% |
| Sep 30, 2025 | 188 | -106 | -36.05% |
| Jun 30, 2025 | 197 | -107 | -35.20% |
| Mar 31, 2025 | 259 | -50 | -16.18% |
| Dec 31, 2024 | 261 | -62 | -19.20% |
| Sep 30, 2024 | 294 | -49 | -14.29% |
| Jun 30, 2024 | 304 | -41 | -11.88% |
| Mar 31, 2024 | 309 | -19 | -5.79% |
| Dec 31, 2023 | 323 | -4 | -1.22% |
| Sep 30, 2023 | 343 | 23 | 7.19% |
| Jun 30, 2023 | 345 | 40 | 13.11% |
| Mar 31, 2023 | 328 | 52 | 18.84% |
| Dec 31, 2022 | 327 | 82 | 33.47% |
| Sep 30, 2022 | 320 | 88 | 37.93% |
| Jun 30, 2022 | 305 | 102 | 50.25% |
| Mar 31, 2022 | 276 | 113 | 69.33% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 522 |
| Denali Therapeutics | 507 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Alumis | 227 |
RLAY News
- 15 hours ago - Relay Therapeutics price target raised to $26 from $22 at Guggenheim - TheFly
- 16 hours ago - Relay Therapeutics price target raised to $28 from $25 at H.C. Wainwright - TheFly
- 6 days ago - Relay Therapeutics 22.9M share Secondary priced at $12.00 - TheFly
- 6 days ago - Relay Therapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 6 days ago - Relay Therapeutics price target raised to $21 from $19 at Citizens - TheFly
- 6 days ago - Relay Therapeutics price target raised to $27 from $21 at Barclays - TheFly
- 7 days ago - Relay Therapeutics announces $175M common stock offering - TheFly
- 7 days ago - Relay Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewsWire